Approval · Notice of Compliance 682 · 2002
REFACTO: Notice of Compliance 682
Issued May 28, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 682
- Date
- May 28, 2002
- Company
- Wyeth-Ayerst Canada Inc.St. Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antihemorrhagic blood coagulation factor viii
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REFACTO | 02245949 | — |
| REFACTO | 02245950 | — |
| REFACTO | 02245951 | Cancelled Post Market |
Medicinal ingredients
- MOROCTOCOG ALFA 250 UNIT per VIAL
- MOROCTOCOG ALFA 500 UNIT per VIAL
- MOROCTOCOG ALFA 1,000 UNIT per VIAL